Amacker M - Search Results

1

A new and versatile virosomal antigen delivery system to induce cellular and humoral immune responses.

Kammer AR, Amacker M, Rasi S, Westerfeld N, Gremion C, Neuhaus D, Zurbriggen R. Kammer AR, et al. Among authors: amacker m. Vaccine. 2007 Oct 10;25(41):7065-74. doi: 10.1016/j.vaccine.2007.07.052. Epub 2007 Aug 14. Vaccine. 2007. PMID: 17766014

2

Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells.

Amacker M, Engler O, Kammer AR, Vadrucci S, Oberholzer D, Cerny A, Zurbriggen R. Amacker M, et al. Int Immunol. 2005 Jun;17(6):695-704. doi: 10.1093/intimm/dxh249. Epub 2005 Apr 20. Int Immunol. 2005. PMID: 15843436

3

Efficient induction of tumoricidal cytotoxic T lymphocytes by HLA-A0201 restricted, melanoma associated, L(27)Melan-A/MART-1(26-35) peptide encapsulated into virosomes in vitro.

Schumacher R, Amacker M, Neuhaus D, Rosenthal R, Groeper C, Heberer M, Spagnoli GC, Zurbriggen R, Adamina M. Schumacher R, et al. Among authors: amacker m. Vaccine. 2005 Dec 1;23(48-49):5572-82. doi: 10.1016/j.vaccine.2005.07.099. Epub 2005 Aug 15. Vaccine. 2005. PMID: 16165256

4

Virosome-based active immunization targets soluble amyloid species rather than plaques in a transgenic mouse model of Alzheimer's disease.

Zurbriggen R, Amacker M, Kammer AR, Westerfeld N, Borghgraef P, Van Leuven F, Van der Auwera I, Wera S. Zurbriggen R, et al. Among authors: amacker m. J Mol Neurosci. 2005;27(2):157-66. doi: 10.1385/JMN:27:2:157. J Mol Neurosci. 2005. PMID: 16186626

5

Virosome-mediated delivery of tumor antigen to plasmacytoid dendritic cells.

Angel J, Chaperot L, Molens JP, Mezin P, Amacker M, Zurbriggen R, Grichine A, Plumas J. Angel J, et al. Among authors: amacker m. Vaccine. 2007 May 10;25(19):3913-21. doi: 10.1016/j.vaccine.2007.01.101. Epub 2007 Feb 15. Vaccine. 2007. PMID: 17336432

6

Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations.

Moser C, Amacker M, Kammer AR, Rasi S, Westerfeld N, Zurbriggen R. Moser C, et al. Among authors: amacker m. Expert Rev Vaccines. 2007 Oct;6(5):711-21. doi: 10.1586/14760584.6.5.711. Expert Rev Vaccines. 2007. PMID: 17931152 Free article. Review.

7

Respiratory syncytial virus subunit vaccine based on a recombinant fusion protein expressed transiently in mammalian cells.

Nallet S, Amacker M, Westerfeld N, Baldi L, König I, Hacker DL, Zaborosch C, Zurbriggen R, Wurm FM. Nallet S, et al. Among authors: amacker m. Vaccine. 2009 Oct 30;27(46):6415-9. doi: 10.1016/j.vaccine.2009.06.019. Epub 2009 Jun 24. Vaccine. 2009. PMID: 19559121

8

Influenza virosomes as a vaccine adjuvant and carrier system.

Moser C, Amacker M, Zurbriggen R. Moser C, et al. Among authors: amacker m. Expert Rev Vaccines. 2011 Apr;10(4):437-46. doi: 10.1586/erv.11.15. Expert Rev Vaccines. 2011. PMID: 21506642 Free article. Review.

9

Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations.

Tamborrini M, Stoffel SA, Westerfeld N, Amacker M, Theisen M, Zurbriggen R, Pluschke G. Tamborrini M, et al. Among authors: amacker m. Malar J. 2011 Dec 13;10:359. doi: 10.1186/1475-2875-10-359. Malar J. 2011. PMID: 22166048 Free PMC article.

10

A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models.

De Bernardis F, Amacker M, Arancia S, Sandini S, Gremion C, Zurbriggen R, Moser C, Cassone A. De Bernardis F, et al. Among authors: amacker m. Vaccine. 2012 Jun 22;30(30):4490-8. doi: 10.1016/j.vaccine.2012.04.069. Epub 2012 May 3. Vaccine. 2012. PMID: 22561143

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters